Another case series evaluated in 2023 examining four patients saw that rhabdomyolysis developed 1-15 days after levetiracetam was initiated, with pathognomonic serum CPK levels rising despite appropriate hydration. This evidence concerns the gene PIK3C2A and rhabdomyolysis.